All stock reports

POLYMED evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-28T14:01:26.267070+00:00

Metrics

latest_annual_period
2026-03-31
revenue
18752592000.0
net_income
3221396000.0
operating_cash_flow
2482205000.0
free_cash_flow
-601714000.0
total_assets
39185672000.0
total_liabilities
7693240000.0
total_equity
31061727000.0
cash
878700000.0
total_debt
3535759000.0
revenue_growth
0.12302294434959782
earnings_growth
-0.048492839614694305
net_margin
0.171784039241082
roe
0.10370949432399557
debt_to_equity
0.11383008420620012
cash_conversion
0.7705370590886684
free_cash_flow_margin
-0.03208697762954583
trailing_pe
52.5599
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
5.4772
dividend_yield
0.0021

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-3c5c83737e21a815b2fa4bbe433e2828533b83c0e38f88b04c89ef3120e3d3a0
Policy
stock-decisions-v1
Evidence bundle hash
a71635c24645fb7af0c5ae6b9fbf673e3660ede7736bc981360c0f970c2512c6
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 63f8f59ce56dd1104a75d0f0b4343a495e3997de0fceb23590baa1aab3c1e5ac
  • daily-price: a0a8d67ec54ff69b817c2b889a9fcc4c7f67a283a0bed88b23a259755c09e668
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 250-session price return was -19.21%. The cached financial metric revenue growth is 0.12302294434959782. The cached financial metric net margin is 0.171784039241082.

Risks

The trailing 5-session price return was -4.54%. The trailing 20-session price return was -8.17%. The closing price was -20.45% below its highest close in the available trailing year. Financial data check: balance_sheet_equation: difference=430705000.00. The cached financial metric free cash flow margin is -0.03208697762954583. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Average cached traded value over twenty sessions was INR 191,301,303. The cached financial metric roe is 0.10370949432399557. The cached financial metric debt to equity is 0.11383008420620012. The cached financial metric cash conversion is 0.7705370590886684.

Cached observations and evidence limits